Essential Tremor

SAN DIEGO — A peripheral nerve stimulator powered by AI and worn as a wristband improved essential tremor symptoms and patients’ ability to perform daily activities compared with a sham device, data from the TRANQUIL trial show.

Deep brain stimulation (DBS) therapy has been a safe and effective treatment option for Parkinson’s disease for more than 30 years, but another surgical option for the therapy has emerged.

The FDA has approved Medtronic’s Asleep Deep Brain Stimulation surgery for individuals diagnosed with Parkinson’s disease as well as those with essential tremor, according to the manufacturer.

DENVER — A phase 3 trial of ulixacaltamide for essential tremor will involve at-home patient participation and a clinical endpoint of activities of daily living, according to a speaker at the American Academy of Neurology annual meeting.

To mark this April as Parkinson’s Awareness Month, the Parkinson’s Foundation has created the #ABCsofPD to provide information about relevant symptoms, statistics and treatments.

The FDA has approved a battery-powered rechargeable deep brain stimulation system for patients with Parkinson’s disease and other disorders such as essential tremor, epilepsy and dystonia, according to the manufacturer.

Individuals with essential tremor may have an increased risk of decline in attentional abilities when having less habitual sleep efficiency, according to a poster presentation at the Alzheimer’s Association International Conference.

The FDA has approved a software update for a deep brain stimulation system intended to assist clinicians in the treatment of those with Parkinson’s disease or essential tremor.

Cala Trio, a wrist-worn device that stimulates wrist nerves to disrupt tremulous activity in the brain, safely and effectively reduced essential tremor in patients, data from a prospective study showed.